<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:yandex="http://news.yandex.ru" xmlns:media="http://search.yahoo.com/mrss/" xmlns:turbo="http://turbo.yandex.ru"><channel><title>biotechnology on Logotyp.us</title><link>https://logotyp.us/tags/biotechnology/</link><description>Recent content in biotechnology on Logotyp.us</description><generator>Hugo -- gohugo.io</generator><language>en-us</language><lastBuildDate>Sun, 01 Aug 2021 00:32:00 +0000</lastBuildDate><atom:link href="https://logotyp.us/tags/biotechnology/index.xml" rel="self" type="application/rss+xml"/><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>AstraZeneca Logo</h1><figure><img src="https://logotyp.us/files/astrazeneca.svg"/></figure></header>
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It is perhaps best known for its involvement in developing the Oxford-AstraZeneca COVID-19 vaccine. The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group.<p>You can download theAstraZenecalogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/astrazeneca.svg</url><title>AstraZenecaLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">AstraZeneca</title><link turbo="true">https://logotyp.us/logo/astrazeneca/</link><pubDate>Sun, 01 Aug 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/astrazeneca/</guid><description turbo="true">AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It is perhaps best known for its involvement in developing the Oxford-AstraZeneca COVID-19 vaccine. The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group.</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>Biogen Logo</h1><figure><img src="https://logotyp.us/files/biogen.svg"/></figure></header>
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
Source<p>You can download theBiogenlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/biogen.svg</url><title>BiogenLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Biogen</title><link turbo="true">https://logotyp.us/logo/biogen/</link><pubDate>Sun, 01 Aug 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/biogen/</guid><description turbo="true"> Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>10x Genomics Logo</h1><figure><img src="https://logotyp.us/files/10x-genomics.svg"/></figure></header>
10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.
Source<p>You can download the10x Genomicslogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/10x-genomics.svg</url><title>10x GenomicsLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">10x Genomics</title><link turbo="true">https://logotyp.us/logo/10x-genomics/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/10x-genomics/</guid><description turbo="true"> 10x Genomics, Inc. is an American biotechnology company that designs and manufactures gene sequencing technology used in scientific research. It was founded in 2012 by Serge Saxonov, Ben Hindson, and Kevin Ness.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>Actelion Logo</h1><figure><img src="https://logotyp.us/files/actelion.svg"/></figure></header>
Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland. Actelion focuses on the manufacture of drugs that treat rare diseases and orphan diseases. Some of the drugs it has produced have been used to treat patients with symptoms related to central nervous system disorders, irregular heart conditions, immune system disorders and cancer. One of the focuses of Actelion is treating individuals with Pulmonary Arterial Hypertension, a heart condition that leaves patients with a short life expectancy even with treatment.<p>You can download theActelionlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/actelion.svg</url><title>ActelionLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Actelion</title><link turbo="true">https://logotyp.us/logo/actelion/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/actelion/</guid><description turbo="true">Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland. Actelion focuses on the manufacture of drugs that treat rare diseases and orphan diseases. Some of the drugs it has produced have been used to treat patients with symptoms related to central nervous system disorders, irregular heart conditions, immune system disorders and cancer. One of the focuses of Actelion is treating individuals with Pulmonary Arterial Hypertension, a heart condition that leaves patients with a short life expectancy even with treatment.</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1> Amylin Pharmaceuticals Logo</h1><figure><img src="https://logotyp.us/files/amylin.svg"/></figure></header>
Amylin Pharmaceuticals was a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company was engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Amylin produced three drugs: Symlin, Byetta and Bydureon.
Source<p>You can download theAmylinlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/amylin.svg</url><title>AmylinLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Amylin</title><link turbo="true">https://logotyp.us/logo/amylin/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/amylin/</guid><description turbo="true"> Amylin Pharmaceuticals was a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company was engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Amylin produced three drugs: Symlin, Byetta and Bydureon.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>AveXis Logo</h1><figure><img src="https://logotyp.us/files/avexis.svg"/></figure></header>
AveXis is a biotechnology company that develops treatments for rare neurological genetic disorders. It was founded in 2015 by Brian Kaspar around a discovery of a novel method of treating spinal muscular atrophy using gene therapy. AveXis was acquired by Novartis in 2018 for USD 8.7 billion. In 2019, Avexis&amp;rsquo;s first gene therapy drug onasemnogene abeparvovec received regulatory approval in the United States and has a list price of USD 2.<p>You can download theAveXislogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/avexis.svg</url><title>AveXisLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">AveXis</title><link turbo="true">https://logotyp.us/logo/avexis/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/avexis/</guid><description turbo="true">AveXis is a biotechnology company that develops treatments for rare neurological genetic disorders. It was founded in 2015 by Brian Kaspar around a discovery of a novel method of treating spinal muscular atrophy using gene therapy. AveXis was acquired by Novartis in 2018 for USD 8.7 billion. In 2019, Avexis&amp;rsquo;s first gene therapy drug onasemnogene abeparvovec received regulatory approval in the United States and has a list price of USD 2.</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>Bavarian Nordic Logo</h1><figure><img src="https://logotyp.us/files/bavarian-nordic.svg"/></figure></header>
Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company is headquartered in Kvistgaard, Denmark, where it also operates a commercial-scale manufacturing facility. The company has a research and development facility in Martinsried, Germany and an office in Morrisville, North Carolina. The company uses viral vectors in its research and development.
Source<p>You can download theBavarian Nordiclogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/bavarian-nordic.svg</url><title>Bavarian NordicLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Bavarian Nordic</title><link turbo="true">https://logotyp.us/logo/bavarian-nordic/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/bavarian-nordic/</guid><description turbo="true"> Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company is headquartered in Kvistgaard, Denmark, where it also operates a commercial-scale manufacturing facility. The company has a research and development facility in Martinsried, Germany and an office in Morrisville, North Carolina. The company uses viral vectors in its research and development.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1> BioMarin Pharmaceutical Logo</h1><figure><img src="https://logotyp.us/files/biomarin.svg"/></figure></header>
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin&amp;rsquo;s core business and research is in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials.<p>You can download theBioMarinlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/biomarin.svg</url><title>BioMarinLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">BioMarin</title><link turbo="true">https://logotyp.us/logo/biomarin/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/biomarin/</guid><description turbo="true">BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin&amp;rsquo;s core business and research is in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials.</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1> bioMérieux Logo</h1><figure><img src="https://logotyp.us/files/biomerieux.svg"/></figure></header>
bioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l&amp;rsquo;Étoile, France, close to Lyon. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors. bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases, cancer screening, and monitoring and cardiovascular emergencies.<p>You can download thebioMerieuxlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/biomerieux.svg</url><title>bioMerieuxLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">bioMerieux</title><link turbo="true">https://logotyp.us/logo/biomerieux/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/biomerieux/</guid><description turbo="true">bioMérieux SA is a French multinational biotechnology company founded and headquartered in Marcy-l&amp;rsquo;Étoile, France, close to Lyon. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors. bioMérieux provides diagnostic solutions which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases, cancer screening, and monitoring and cardiovascular emergencies.</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>BioNTech Logo</h1><figure><img src="https://logotyp.us/files/biontech.svg"/></figure></header>
BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops pharmaceutical candidates based on messenger ribonucleic acid for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement therapies for rare diseases, and also engineered cell therapy, novel antibodies and small molecule immunomodulators as treatment options for cancer. The company has developed an mRNA-based human therapeutic for intravenous administration to bring individualized mRNA-based cancer immunotherapy to clinical trials and to establish its own manufacturing process.<p>You can download theBioNTechlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/biontech.svg</url><title>BioNTechLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">BioNTech</title><link turbo="true">https://logotyp.us/logo/biontech/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/biontech/</guid><description turbo="true">BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops pharmaceutical candidates based on messenger ribonucleic acid for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement therapies for rare diseases, and also engineered cell therapy, novel antibodies and small molecule immunomodulators as treatment options for cancer. The company has developed an mRNA-based human therapeutic for intravenous administration to bring individualized mRNA-based cancer immunotherapy to clinical trials and to establish its own manufacturing process.</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>Celgene Logo</h1><figure><img src="https://logotyp.us/files/celgene.svg"/></figure></header>
Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid, which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol-Myers Squibb.
Source<p>You can download theCelgenelogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/celgene.svg</url><title>CelgeneLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Celgene</title><link turbo="true">https://logotyp.us/logo/celgene/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/celgene/</guid><description turbo="true"> Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid, which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol-Myers Squibb.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1> CSL Limited Logo</h1><figure><img src="https://logotyp.us/files/csl.svg"/></figure></header>
CSL Limited is a global specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL&amp;rsquo;s product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications.
Source<p>You can download theCSLlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/csl.svg</url><title>CSLLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">CSL</title><link turbo="true">https://logotyp.us/logo/csl/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/csl/</guid><description turbo="true"> CSL Limited is a global specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL&amp;rsquo;s product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1> DBV Technologies Logo</h1><figure><img src="https://logotyp.us/files/dbv.svg"/></figure></header>
DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing &amp;ldquo;Viaskin&amp;rdquo; technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.
Source<p>You can download theDBVlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/dbv.svg</url><title>DBVLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">DBV</title><link turbo="true">https://logotyp.us/logo/dbv/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/dbv/</guid><description turbo="true"> DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing &amp;ldquo;Viaskin&amp;rdquo; technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>DiaSorin Logo</h1><figure><img src="https://logotyp.us/files/diasorin.svg"/></figure></header>
DiaSorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics. The group was founded in 2000 and is headquartered in Saluggia, Italy. Its production is at several plants located in Europe and the United States: Saluggia and Gerenzano, Dietzenbach, Stillwater, Minnesota, Dartford. The company is a constituent of the FTSE Italia Mid Cap index. The Group is active in the development, production and marketing of diagnostic tests used by the medical community to assess a patient&amp;rsquo;s values, understand their state of health or monitor the progression of a disease.<p>You can download theDiaSorinlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/diasorin.svg</url><title>DiaSorinLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">DiaSorin</title><link turbo="true">https://logotyp.us/logo/diasorin/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/diasorin/</guid><description turbo="true">DiaSorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics. The group was founded in 2000 and is headquartered in Saluggia, Italy. Its production is at several plants located in Europe and the United States: Saluggia and Gerenzano, Dietzenbach, Stillwater, Minnesota, Dartford. The company is a constituent of the FTSE Italia Mid Cap index. The Group is active in the development, production and marketing of diagnostic tests used by the medical community to assess a patient&amp;rsquo;s values, understand their state of health or monitor the progression of a disease.</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>Evotec Logo</h1><figure><img src="https://logotyp.us/files/evotec.svg"/></figure></header>
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of December 31, 2019, Evotec had a market capitalization of €3.47 billion and a pipeline of more than 100 partnered programs in discovery, pre-clinical development and clinical development. The company&amp;rsquo;s 2,000+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases.<p>You can download theEvoteclogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/evotec.svg</url><title>EvotecLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Evotec</title><link turbo="true">https://logotyp.us/logo/evotec/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/evotec/</guid><description turbo="true">Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of December 31, 2019, Evotec had a market capitalization of €3.47 billion and a pipeline of more than 100 partnered programs in discovery, pre-clinical development and clinical development. The company&amp;rsquo;s 2,000+ employees work across a number of therapeutic areas including CNS/neurology, metabolic diseases, Cancer, and inflammatory and infectious diseases.</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>Genmab Logo</h1><figure><img src="https://logotyp.us/files/genmab.svg"/></figure></header>
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark - internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, USA, and Genmab K.K. in Tokyo, Japan.
Source<p>You can download theGenmablogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/genmab.svg</url><title>GenmabLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Genmab</title><link turbo="true">https://logotyp.us/logo/genmab/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/genmab/</guid><description turbo="true"> Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark - internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, USA, and Genmab K.K. in Tokyo, Japan.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1> Genus plc Logo</h1><figure><img src="https://logotyp.us/files/genus.svg"/></figure></header>
Genus plc is a British-based business selling elite genetics and other products manufactured using biotechnology to cattle and pig farmers. It is headquartered in Basingstoke and is a constituent of the FTSE 250 Index.
Source<p>You can download theGenuslogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/genus.svg</url><title>GenusLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Genus</title><link turbo="true">https://logotyp.us/logo/genus/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/genus/</guid><description turbo="true"> Genus plc is a British-based business selling elite genetics and other products manufactured using biotechnology to cattle and pig farmers. It is headquartered in Basingstoke and is a constituent of the FTSE 250 Index.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>Genzyme Logo</h1><figure><img src="https://logotyp.us/files/genzyme.svg"/></figure></header>
Sanofi Genzyme is an American biotechnology company based in Cambridge, Massachusetts. Since its acquisition in 2011, Genzyme has been a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world&amp;rsquo;s third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme has a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its products are also sold in 90 countries.<p>You can download theGenzymelogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/genzyme.svg</url><title>GenzymeLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Genzyme</title><link turbo="true">https://logotyp.us/logo/genzyme/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/genzyme/</guid><description turbo="true">Sanofi Genzyme is an American biotechnology company based in Cambridge, Massachusetts. Since its acquisition in 2011, Genzyme has been a fully owned subsidiary of Sanofi. In 2010, Genzyme was the world&amp;rsquo;s third-largest biotechnology company, employing more than 11,000 people around the world. As a subsidiary of Sanofi, Genzyme has a presence in approximately 65 countries, including 17 manufacturing facilities and 9 genetic-testing laboratories. Its products are also sold in 90 countries.</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>Illumina Logo</h1><figure><img src="https://logotyp.us/files/illumina.svg"/></figure></header>
Illumina, Inc. is an American company incorporated in April 1998 that develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serve the sequencing, genotyping and gene expression and proteomics markets. Its headquarters are located in San Diego, California.
Source<p>You can download theIlluminalogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/illumina.svg</url><title>IlluminaLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Illumina</title><link turbo="true">https://logotyp.us/logo/illumina/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/illumina/</guid><description turbo="true"> Illumina, Inc. is an American company incorporated in April 1998 that develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serve the sequencing, genotyping and gene expression and proteomics markets. Its headquarters are located in San Diego, California.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1> Intercell AG Logo</h1><figure><img src="https://logotyp.us/files/intercell.svg"/></figure></header>
Intercell AG was a biotechnology company based in Vienna which focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases. The company merged with Vivalis to form Valneva SE in 2012. Intercell was formed in 1998 as a spin-off of the Research Institute of Molecular Pathology in Vienna.It employs 400 people in Austria, Scotland and the United States. It has been listed on the Vienna Stock Exchange since February 28, 2005.<p>You can download theIntercelllogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/intercell.svg</url><title>IntercellLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Intercell</title><link turbo="true">https://logotyp.us/logo/intercell/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/intercell/</guid><description turbo="true">Intercell AG was a biotechnology company based in Vienna which focused on the development of modern prophylactic and therapeutic vaccines against infectious diseases. The company merged with Vivalis to form Valneva SE in 2012. Intercell was formed in 1998 as a spin-off of the Research Institute of Molecular Pathology in Vienna.It employs 400 people in Austria, Scotland and the United States. It has been listed on the Vienna Stock Exchange since February 28, 2005.</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1> Ionis Pharmaceuticals Logo</h1><figure><img src="https://logotyp.us/files/ionis.svg"/></figure></header>
Ionis Pharmaceuticals is a biotechnology company based in Carlsbad, California that specializes in discovering and developing RNA-targeted therapeutics. The company has 3 commercially approved medicines: Spinraza, Tegsedi, and WAYLIVRA and has 4 drugs in pivotal studies: tominersen for Huntington&amp;rsquo;s disease, tofersen for SOD1-ALS, AKCEA-APO-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis. The company was named Isis Pharmaceuticals until December 2015.
Source<p>You can download theIonislogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/ionis.svg</url><title>IonisLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Ionis</title><link turbo="true">https://logotyp.us/logo/ionis/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/ionis/</guid><description turbo="true"> Ionis Pharmaceuticals is a biotechnology company based in Carlsbad, California that specializes in discovering and developing RNA-targeted therapeutics. The company has 3 commercially approved medicines: Spinraza, Tegsedi, and WAYLIVRA and has 4 drugs in pivotal studies: tominersen for Huntington&amp;rsquo;s disease, tofersen for SOD1-ALS, AKCEA-APO-LRx for cardiovascular disease, and AKCEA-TTR-LRx for all forms of TTR amyloidosis. The company was named Isis Pharmaceuticals until December 2015.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1> Kyowa Hakko Kirin Logo</h1><figure><img src="https://logotyp.us/files/kyowa-kirin.svg"/></figure></header>
Kyowa Kirin Co., Ltd. is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index.
Source<p>You can download theKyowa Kirinlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/kyowa-kirin.svg</url><title>Kyowa KirinLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Kyowa Kirin</title><link turbo="true">https://logotyp.us/logo/kyowa-kirin/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/kyowa-kirin/</guid><description turbo="true"> Kyowa Kirin Co., Ltd. is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1> Lonza Group Logo</h1><figure><img src="https://logotyp.us/files/lonza.svg"/></figure></header>
Lonza Group is a Swiss multinational chemicals and biotechnology company, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including organic, fine and performance chemicals, custom manufacturing of biopharmaceuticals, chemical synthesis capabilities, detection systems and services for the bioscience sector.
Source<p>You can download theLonzalogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/lonza.svg</url><title>LonzaLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Lonza</title><link turbo="true">https://logotyp.us/logo/lonza/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/lonza/</guid><description turbo="true"> Lonza Group is a Swiss multinational chemicals and biotechnology company, headquartered in Basel, with major facilities in Europe, North America and South Asia. Lonza was established under that name in the late 19th-century in Switzerland. The company provides product development services to the pharmaceutical and biologic industries, including organic, fine and performance chemicals, custom manufacturing of biopharmaceuticals, chemical synthesis capabilities, detection systems and services for the bioscience sector.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>Luminex Logo</h1><figure><img src="https://logotyp.us/files/luminex.svg"/></figure></header>
Luminex Corporation is an American biotechnology company which develops, manufactures and markets proprietary biological testing technologies with applications in life-sciences. Nachum &amp;ldquo;Homi&amp;rdquo; Shamir has served as Luminex&amp;rsquo;s President and Chief Executive Officer since October, 2014. Luminex was recognized by Forbes magazine as one of the top 25 fastest growing technology companies in the US in 2011.
Source<p>You can download theLuminexlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/luminex.svg</url><title>LuminexLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Luminex</title><link turbo="true">https://logotyp.us/logo/luminex/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/luminex/</guid><description turbo="true"> Luminex Corporation is an American biotechnology company which develops, manufactures and markets proprietary biological testing technologies with applications in life-sciences. Nachum &amp;ldquo;Homi&amp;rdquo; Shamir has served as Luminex&amp;rsquo;s President and Chief Executive Officer since October, 2014. Luminex was recognized by Forbes magazine as one of the top 25 fastest growing technology companies in the US in 2011.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>MorphoSys Logo</h1><figure><img src="https://logotyp.us/files/morphosys.svg"/></figure></header>
MorphoSys AG is a biopharmaceutical company founded in 1992. The company is headquartered near Munich, Germany and has a wholly owned subsidiary, MorphoSys US Inc., in Boston MA in the US, where it is building a commercial organization. The company has various antibody, protein and peptide technologies that it uses to discover and develop both proprietary and partnered drug candidates. The company claims to have more than 100 drugs in its wider pipeline that are being investigated for a variety of diseases.<p>You can download theMorphoSyslogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/morphosys.svg</url><title>MorphoSysLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">MorphoSys</title><link turbo="true">https://logotyp.us/logo/morphosys/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/morphosys/</guid><description turbo="true">MorphoSys AG is a biopharmaceutical company founded in 1992. The company is headquartered near Munich, Germany and has a wholly owned subsidiary, MorphoSys US Inc., in Boston MA in the US, where it is building a commercial organization. The company has various antibody, protein and peptide technologies that it uses to discover and develop both proprietary and partnered drug candidates. The company claims to have more than 100 drugs in its wider pipeline that are being investigated for a variety of diseases.</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1> PRA Health Sciences Logo</h1><figure><img src="https://logotyp.us/files/pra.svg"/></figure></header>
PRA Health Sciences is a contract research organization with headquarters in Raleigh, North Carolina that was founded as the Anti-Inflammatory Drug Study Group in 1976, renamed PRA in 1982. In 2013 the company was acquired by Kohlberg Kravis Roberts, which brought the company public in November 2014 and maintained shares until September 2019. In August 2017 the company acquired Conshohocken-based real-world healthcare data, analytics, and technology solutions company Symphony Health for US$530 million.<p>You can download thePRAlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/pra.svg</url><title>PRALogo</title><link>https://www.w3schools.com</link></image><title turbo="true">PRA</title><link turbo="true">https://logotyp.us/logo/pra/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/pra/</guid><description turbo="true">PRA Health Sciences is a contract research organization with headquarters in Raleigh, North Carolina that was founded as the Anti-Inflammatory Drug Study Group in 1976, renamed PRA in 1982. In 2013 the company was acquired by Kohlberg Kravis Roberts, which brought the company public in November 2014 and maintained shares until September 2019. In August 2017 the company acquired Conshohocken-based real-world healthcare data, analytics, and technology solutions company Symphony Health for US$530 million.</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1> Regeneron Pharmaceuticals Logo</h1><figure><img src="https://logotyp.us/files/regeneron.svg"/></figure></header>
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York, about 25 miles north of Midtown Manhattan. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.
Source<p>You can download theRegeneronlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/regeneron.svg</url><title>RegeneronLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Regeneron</title><link turbo="true">https://logotyp.us/logo/regeneron/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/regeneron/</guid><description turbo="true"> Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York, about 25 miles north of Midtown Manhattan. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company then branched out into the study of both cytokine and tyrosine kinase receptors.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1> MilliporeSigma Logo</h1><figure><img src="https://logotyp.us/files/sigma-aldrich.svg"/></figure></header>
MilliporeSigma is an American chemical, life science and biotechnology company, before 2014 known as Sigma-Aldrich, owned by Merck KGaA. Created by the 1975 merger of Sigma Chemical Company and Aldrich Chemical Company, Sigma-Aldrich since grew through various acquisitions until it had over 9,600 employees and was listed on the Fortune 1000 at the time of its acquisition by Merck. The company is headquartered in St. Louis and has operations in approximately 40 countries.<p>You can download theSigma Aldrichlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/sigma-aldrich.svg</url><title>Sigma AldrichLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Sigma Aldrich</title><link turbo="true">https://logotyp.us/logo/sigma-aldrich/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/sigma-aldrich/</guid><description turbo="true">MilliporeSigma is an American chemical, life science and biotechnology company, before 2014 known as Sigma-Aldrich, owned by Merck KGaA. Created by the 1975 merger of Sigma Chemical Company and Aldrich Chemical Company, Sigma-Aldrich since grew through various acquisitions until it had over 9,600 employees and was listed on the Fortune 1000 at the time of its acquisition by Merck. The company is headquartered in St. Louis and has operations in approximately 40 countries.</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>Sumitomo Dainippon Pharma Logo</h1><figure><img src="https://logotyp.us/files/sumitomo-dainippon-pharma.svg"/></figure></header>
Sumitomo Dainippon Pharma Co., Ltd. is a pharmaceutical company based in Japan. Its headquarters are in Chuo-ku, Osaka. The original Dainippon Pharmaceuticals was established in 1885 by Nagayo Sensai, a graduate of Tekijuku – the first private medical school in Japan established by Ogata Kōan. It was set up as a wholly private company invested by a number of people in Tokyo and Osaka, with the land and buildings let by the government.<p>You can download theSumitomo Dainippon Pharmalogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/sumitomo-dainippon-pharma.svg</url><title>Sumitomo Dainippon PharmaLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Sumitomo Dainippon Pharma</title><link turbo="true">https://logotyp.us/logo/sumitomo-dainippon-pharma/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/sumitomo-dainippon-pharma/</guid><description turbo="true">Sumitomo Dainippon Pharma Co., Ltd. is a pharmaceutical company based in Japan. Its headquarters are in Chuo-ku, Osaka. The original Dainippon Pharmaceuticals was established in 1885 by Nagayo Sensai, a graduate of Tekijuku – the first private medical school in Japan established by Ogata Kōan. It was set up as a wholly private company invested by a number of people in Tokyo and Osaka, with the land and buildings let by the government.</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1> Verily Life Sciences Logo</h1><figure><img src="https://logotyp.us/files/verily.svg"/></figure></header>
Verily is Alphabet Inc.&amp;rsquo;s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, until 10 August 2015 when Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc. This restructuring process was completed on October 2, 2015. On December 7, 2015, Google Life Sciences was renamed Verily.
Source<p>You can download theVerilylogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/verily.svg</url><title>VerilyLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Verily</title><link turbo="true">https://logotyp.us/logo/verily/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/verily/</guid><description turbo="true"> Verily is Alphabet Inc.&amp;rsquo;s research organization devoted to the study of life sciences. The organization was formerly a division of Google X, until 10 August 2015 when Sergey Brin announced that the organization would become an independent subsidiary of Alphabet Inc. This restructuring process was completed on October 2, 2015. On December 7, 2015, Google Life Sciences was renamed Verily.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>Zymeworks Logo</h1><figure><img src="https://logotyp.us/files/zymeworks.svg"/></figure></header>
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company&amp;rsquo;s molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year.<p>You can download theZymeworkslogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/zymeworks.svg</url><title>ZymeworksLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Zymeworks</title><link turbo="true">https://logotyp.us/logo/zymeworks/</link><pubDate>Mon, 19 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/zymeworks/</guid><description turbo="true">Zymeworks Inc. is a publicly held biotechnology company based in Vancouver, British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases. The products are based upon the company&amp;rsquo;s molecular modeling software for optimizing protein structure. In 2014, Zymeworks raised $44 million across various funding rounds according to PitchBook, placing it among the top 10 HealthTech businesses in the world to raise the most capital that year.</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1>Genentech Logo</h1><figure><img src="https://logotyp.us/files/genentech.svg"/></figure></header>
Genentech, Inc., is an American biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. As of February 2020, Genentech employed 13,638 people.
Source<p>You can download theGenentechlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/genentech.svg</url><title>GenentechLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">Genentech</title><link turbo="true">https://logotyp.us/logo/genentech/</link><pubDate>Sun, 18 Jul 2021 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/genentech/</guid><description turbo="true"> Genentech, Inc., is an American biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche. As of February 2020, Genentech employed 13,638 people.
Source</description></item><item turbo="true"><turbo:content>
&lt;! [CDATA[<header><h1> GlaxoSmithKline plc (GSK) Logo</h1><figure><img src="https://logotyp.us/files/gsk.svg"/></figure></header>
GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world&amp;rsquo;s sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi. Source<p>You can download theGSKlogo on full-version of the page.</p>
]] ></turbo:content><image turbo="true"><url>https://logotyp.us/files/gsk.svg</url><title>GSKLogo</title><link>https://www.w3schools.com</link></image><title turbo="true">GSK</title><link turbo="true">https://logotyp.us/logo/gsk/</link><pubDate>Wed, 11 Sep 2019 00:32:00 +0000</pubDate><guid>https://logotyp.us/logo/gsk/</guid><description turbo="true"> GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in Brentford, London. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, GSK was the world&amp;rsquo;s sixth largest pharmaceutical company as of 2015, after Pfizer, Novartis, Merck, Hoffmann-La Roche and Sanofi. Source</description></item></channel></rss>